A preliminary modeling study suggests that four variables accessible at discharge could predict the risk for 90-day ...

Older adults with moderate to severe IBD can achieve remission with JAK inhibitors, according to a study presented at Crohn’s & Colitis Congress.

Phase 2 clinical trial shows a safe dose from a specific donor helped with gut microbiome recovery in people with cancer ...